Deng X, Zhang C, Wang P, Wei W, et al. Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes. J Clin Endocrinol Metab 2022 Apr 9. pii: 6565990. doi: 10.1210.
PMID: 35397165